MnO2 apoferritin NPs that target the transferrin receptor were loaded with doxorubicin. Treatment of 4T1 tumor bearing mice led to a strongly reduced tumor growth which was supposed to be based on a synergistic effect of MnO2 to increase the oxygen level and doxorubicin. This evidence concerns the gene TFRC and neoplasm.